LEI 636700ITSLXVAJVLAY33

AstraZeneca AB

Group parent: ASTRAZENECA PLCAZN · LN

Awards tracked

102

Value (latest 100)

€26.57M

Countries

SE

Download sample CSV

Contract awards & public grants

A doctoral training programme for next-generation LUNG-targeted non-viral GENEtic MEDicines → ASTRAZENECA AB

European Commission · SE · Grant · 2026-07-08

—

Deciphering the Splicing Code in Human Disease → ASTRAZENECA AB

European Commission · SE · Grant · 2026-07-02

€324,630

Accelerating Innovation in Marine AI-powered Bioprospecting → ASTRAZENECA AB

European Commission · SE · Grant · 2026-05-19

—

Molecular Dynamics for Structure-based Biology → ASTRAZENECA AB

European Commission · SE · Grant · 2026-05-11

—

EXIT-CVD → ASTRAZENECA AB

European Commission · SE · Grant · 2026-03-31

—

Protein-ligand data generation at scale to support computational hit finding and optimization → ASTRAZENECA AB

European Commission · SE · Grant · 2025-12-17

—

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies → ASTRAZENECA AB

European Commission · SE · Grant · 2025-11-03

—

101218845 - UNIFIED - UNIFYING FRAMEWORK FOR PATIENT-CENTRED CLINICAL-STUDY ENDPOINTS DERIVED FROM DIGITAL HEALTH TECHNOLOGIES → ASTRAZENECA AB

IMI - Innov.Health Initiative · SE · Grant · 2025-11-01

€12.6M

Novel enzymes from extreme marine environments as a source for value-added targets → ASTRAZENECA AB

European Commission · SE · Grant · 2025-10-06

€317,500

OligoNucleotide Technologies for Rapid Advancement of Cancer Therapies → ASTRAZENECA AB

European Commission · SE · Grant · 2025-07-02

—

Advancing Europe's Next Generations on the Path to Sustainability – Expanding the Universe of Enzymatic Halogenation Chemistry → ASTRAZENECA AB

European Commission · SE · Grant · 2025-07-01

—

Improving Life expectancy of LUNG transplant recipients through innovative ex vivo perfusion gene therapy → ASTRAZENECA AB

European Commission · SE · Grant · 2025-06-30

—

Low Data Machine Learning for Sustainable Chemical Sciences → ASTRAZENECA AB

European Commission · SE · Grant · 2025-06-24

€324,630

Machine learning for integrated multi-parametric enzyme and bioprocess design → ASTRAZENECA AB

European Commission · SE · Grant · 2025-06-20

—

Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT) → ASTRAZENECA AB

European Commission · SE · Grant · 2024-12-16

—

REpresentative Clinical Research - ADvancing Inclusivity in Europe → ASTRAZENECA AB

European Commission · SE · Grant · 2024-12-05

—

Non-Animal Platform for Nanoparticle-Based Delivery across the blood-brain barrier Interface with Vehicle Evolution → ASTRAZENECA AB

European Commission · SE · Grant · 2024-11-07

€870,910

SciLifeLab Programme for fUture Leaders in life SciencE → ASTRAZENECA AB

European Commission · SE · Grant · 2024-09-16

—

EUROPEAN RARE DISEASES RESEARCH ALLIANCE → ASTRAZENECA AB

European Commission · SE · Grant · 2024-08-20

—

Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers → ASTRAZENECA AB

European Commission · SE · Grant · 2024-07-10

€293,710

Macrocycles for Drug Discovery → ASTRAZENECA AB

European Commission · SE · Grant · 2024-07-10

€293,710

Mechanical Characterisation of Nucleic Acids using Single Molecule Methods → ASTRAZENECA AB

European Commission · SE · Grant · 2024-07-08

—

A European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across Tissues → ASTRAZENECA AB

European Commission · SE · Grant · 2024-07-05

€293,710

Targeting RNA with small molecules → ASTRAZENECA AB

European Commission · SE · Grant · 2024-06-25

€293,710

Integrated AI Diagnostics in Breast Cancer → ASTRAZENECA AB

European Commission · SE · Grant · 2024-03-13

—

A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy → ASTRAZENECA AB

European Commission · SE · Grant · 2023-11-27

—

Hydrogenases for Large Scale Deployment of H2 as a Circular Energy Carrier in Industrial Biotechnology Based on Enzymatic Catalysts → ASTRAZENECA AB

European Commission · SE · Grant · 2023-11-22

€230,125

INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE → ASTRAZENECA AB

European Commission · SE · Grant · 2023-10-20

—

CURE HEARTandBRAIN postdoctoral COFUND programme by CNIC → ASTRAZENECA AB

European Commission · SE · Grant · 2023-09-19

—

101103234 - CHEMSKILLS - CHEMSKILLS: ENABLING THE GREEN AND DIGITAL SKILLS TRANSFORMATION OF THE CHEMICAL INDUSTRY → ASTRAZENECA AB

EACEA - Education, Audiovisual and Culture Executive Agency · SE · Grant · 2023-09-01

€39,795

Explainable AI for Molecules - AiChemist → ASTRAZENECA AB

European Commission · SE · Grant · 2023-07-14

€587,419

Industry empowerment to Multiphase fluid dynamics simulations using Artificial intelligence and Statistical methods on modern hardware architectures a → ASTRAZENECA AB

European Commission · SE · Grant · 2023-07-13

—

Organoid technologies for disease modeling, drug discovery and development for rare diseases → ASTRAZENECA AB

European Commission · SE · Grant · 2023-07-11

—

Intrinsically disordered proteins in health and disease: mechanisms, molecular context and opportunities for drug discovery → ASTRAZENECA AB

European Commission · SE · Grant · 2023-07-05

—

Medicine Made to Measure. → ASTRAZENECA AB

European Commission · SE · Grant · 2023-07-05

—

Multilevel inflammatory regulation in cardiometabolic disease → ASTRAZENECA AB

European Commission · SE · Grant · 2023-06-28

—

Fluorinated Lipid Nanoparticles for Gene Delivery and Diagnostics → ASTRAZENECA AB

European Commission · SE · Grant · 2023-04-28

—

PhD Research and Innovation in Synchrotron Methods and Applications in Sweden → ASTRAZENECA AB

European Commission · SE · Grant · 2022-11-21

—

Gene Therapy of Rare Diseases → ASTRAZENECA AB

European Commission · SE · Grant · 2022-07-15

€587,419

Isotopic Labeling of Biotherapeutics → ASTRAZENECA AB

European Commission · SE · Grant · 2022-07-14

€587,419

Decoding novel reaction chemistries in biocatalysis – Training Europe’s next visionaries for a sustainable future → ASTRAZENECA AB

European Commission · SE · Grant · 2022-07-06

—

Advancing Reaction Platforms for Drug Discovery → ASTRAZENECA AB

European Commission · SE · Grant · 2022-07-04

€244,758

Assessing efficacy and safety of genome EDITing approaches for Sickle Cell Disease → ASTRAZENECA AB

European Commission · SE · Grant · 2022-05-24

€520,000

Next generation advanced RNA inhibition therapy to treat cardiometabolic disease → ASTRAZENECA AB

European Commission · SE · Grant · 2022-05-24

€50,000

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence → ASTRAZENECA AB

European Commission · SE · Grant · 2021-10-18

—

FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem → ASTRAZENECA AB

European Commission · SE · Grant · 2021-10-11

—

Real World Handling of Protein Drugs - Exploration, Evaluation and Education → ASTRAZENECA AB

European Commission · SE · Grant · 2021-07-05

—

Building a reproducible single-cell experimental workflow to capture tumour cell persistence → ASTRAZENECA AB

European Commission · SE · Grant · 2021-06-28

—

Preparing for RSV Immunisation and Surveillance in Europe → ASTRAZENECA AB

European Commission · SE · Grant · 2021-05-21

—

ENable LIGHT- and synthetic biology-driven volumetric bioprinting of functional human tissues → ASTRAZENECA AB

European Commission · SE · Grant · 2021-01-22

€278,000

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment → ASTRAZENECA AB

European Commission · SE · Grant · 2020-11-12

—

H2O Health Outcomes Observatory → ASTRAZENECA AB

European Commission · SE · Grant · 2020-09-30

—

A fully integrated, animal-free, end-to-end modelling approach to oral drug product development → ASTRAZENECA AB

European Commission · SE · Grant · 2020-09-07

€140,991

Advanced machine learning for Innovative Drug Discovery → ASTRAZENECA AB

European Commission · SE · Grant · 2020-08-24

€790,492

NExt ApplicationS of Quantum Computing → ASTRAZENECA AB

European Commission · SE · Grant · 2020-08-24

€240,500

Boosting advanced doctoral training in innovative colon targeting drugs → ASTRAZENECA AB

European Commission · SE · Grant · 2020-08-19

€281,983

Oligonucleotides for Medical Applications → ASTRAZENECA AB

European Commission · SE · Grant · 2020-08-13

€281,983

Prioritisation and Risk Evaluation of Medicines in the EnviRonment → ASTRAZENECA AB

European Commission · SE · Grant · 2020-06-24

—

C-H Activation for Industrial Renewal → ASTRAZENECA AB

European Commission · SE · Grant · 2020-06-22

€281,983

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory → ASTRAZENECA AB

European Commission · SE · Grant · 2019-12-18

—

PharmaLedger → ASTRAZENECA AB

European Commission · SE · Grant · 2019-12-16

—

EU Patient- cEntric clinicAl tRial pLatform → ASTRAZENECA AB

European Commission · SE · Grant · 2019-11-27

—

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions → ASTRAZENECA AB

European Commission · SE · Grant · 2019-08-22

—

Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery → ASTRAZENECA AB

European Commission · SE · Grant · 2019-08-12

€281,983

Cooperation towards a sustainable chemical industry → ASTRAZENECA AB

European Commission · SE · Grant · 2019-08-09

€281,983

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials → ASTRAZENECA AB

European Commission · SE · Grant · 2019-08-07

—

EXpanding Platforms for Efficacious mRNA Therapeutics → ASTRAZENECA AB

European Commission · SE · Grant · 2019-07-03

€927,500

MachinE Learning Ledger Orchestration for Drug DiscoverY → ASTRAZENECA AB

European Commission · SE · Grant · 2019-05-22

—

INnate-ImmunomeTabolIsm as Antiviral TargEt → ASTRAZENECA AB

European Commission · SE · Grant · 2019-05-21

€281,983

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug → ASTRAZENECA AB

European Commission · SE · Grant · 2019-04-29

—

Saracatinib Trial tO Prevent FOP → ASTRAZENECA AB

European Commission · SE · Grant · 2019-04-17

—

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement → ASTRAZENECA AB

European Commission · SE · Grant · 2019-03-22

—

Neurotoxicity De-Risking in Preclinical Drug Discovery → ASTRAZENECA AB

European Commission · SE · Grant · 2019-03-15

—

FAIRplus → ASTRAZENECA AB

European Commission · SE · Grant · 2018-12-18

—

European Screening Centre; Unique Library for Attractive Biology → ASTRAZENECA AB

European Commission · SE · Grant · 2018-12-18

—

Stirling heat pump for high temperature industrial use → ASTRAZENECA AB

European Commission · SE · Grant · 2018-12-04

€930,244

European Health Data and Evidence Network → ASTRAZENECA AB

European Commission · SE · Grant · 2018-11-22

—

A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment → ASTRAZENECA AB

European Commission · SE · Grant · 2018-09-13

€563,966

The GetReal Initiative → ASTRAZENECA AB

European Commission · SE · Grant · 2018-06-26

—

Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope → ASTRAZENECA AB

European Commission · SE · Grant · 2018-06-14

—

Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections → ASTRAZENECA AB

European Commission · SE · Grant · 2017-10-27

—

Liver Investigation: Testing Marker Utility in Steatohepatitis → ASTRAZENECA AB

European Commission · SE · Grant · 2017-10-09

—

Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management → ASTRAZENECA AB

European Commission · SE · Grant · 2017-09-12

—

Improving Genome Editing Efficiency (IMGENE) → ASTRAZENECA AB

European Commission · SE · Grant · 2017-07-18

€263,659

ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 → ASTRAZENECA AB

European Commission · SE · Grant · 2017-05-18

—

SupercompuTing And Related applicationS Fellows Program → ASTRAZENECA AB

European Commission · SE · Grant · 2017-04-11

—

Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 → ASTRAZENECA AB

European Commission · SE · Grant · 2016-12-22

—

Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 → ASTRAZENECA AB

European Commission · SE · Grant · 2016-12-16

—

REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 → ASTRAZENECA AB

European Commission · SE · Grant · 2016-12-14

—

Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 → ASTRAZENECA AB

European Commission · SE · Grant · 2016-12-07

—

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 → ASTRAZENECA AB

European Commission · SE · Grant · 2016-10-21

—

Molecular Tools for Nucleic Acid Manipulation for Biological Intervention → ASTRAZENECA AB

European Commission · SE · Grant · 2016-08-31

€263,659

PET Imaging in Drug Design and Development → ASTRAZENECA AB

European Commission · SE · Grant · 2016-05-02

€263,659

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → ASTRAZENECA AB

European Commission · SE · Grant · 2015-09-02

—

Accelerated Early staGe drug diScovery → ASTRAZENECA AB

European Commission · SE · Grant · 2015-08-11

€263,659

ISOTOPIC LABELING FOR DRUG INNOVATION → ASTRAZENECA AB

European Commission · SE · Grant · 2015-08-10

€263,659

Synaptic Dysfunction in Alzheimer Disease → ASTRAZENECA AB

European Commission · SE · Grant · 2015-08-06

—

Non-Noble Metal Catalysis - NoNoMeCat → ASTRAZENECA AB

European Commission · SE · Grant · 2015-07-31

—

Big Data in Chemistry → ASTRAZENECA AB

European Commission · SE · Grant · 2015-07-27

€703,092

Targeted small-molecule Stabilisation of Protein-Protein Interactions → ASTRAZENECA AB

European Commission · SE · Grant · 2015-07-20

€527,319

Showing the latest 100 of 102 awards. Full feed via API or CSV

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.